A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
Clinical trial NCT03417102 · COMPLETED
Trial details
- NCT number
- NCT03417102
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-14
- Primary completion
- 2020-11-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.